产品展示更多>>
- Mitiglinide calcium hydrate 207844-01-7
- Mitiglinide calcium hydrate 207844-01-7
Mitiglinide calcium hydrate 207844-01-7
产品描述 描述 Mitiglinide is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic beta-cells. Mitiglinide belongs to the meglitinide class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda.
纯度 99%储存/保存方法 Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution.基本信息 别名 米ge列奈钙；Mitiglinide calcium hydrate；S-21403 calcium hydrate外观 白色或类白色粉末可溶性/溶解性 10 mM in DMSO参考文献 参考文献 1. Malaisse WJ. Expert Opin Pharmacother. 2008 Oct;9(15):2691-8.
2. Ojima K, et al. Nihon Yakurigaku Zasshi. 2004 Oct; 124(4):245-55.
3. Malaisse WJ. Treat Endocrinol. 2003; 2(6):401-14. Review.
研究领域 研究领域 MetabolismDrug DiscoverySmall Molecule DrugLead Compound DiscoveryMitiglinide calcium hydrate 207844-01-7温馨提示：本产品仅作科研实验使用，不支持临床等研究